amifampridine

Amifampridine, also known as 4-aminopyridine, is a medication used to improve walking in adults with lambert-eaton myasthenic syndrome (LEMS). It works by blocking potassium channels in nerve cells, which allows for increased release of acetylcholine at the neuromuscular junction. This leads to improved muscle strength and function. Amifampridine is taken orally, typically three to four times a day. It is important to note that amifampridine can have side effects, including dizziness, headache, and seizures. It is crucial for patients to discuss potential risks and benefits with their healthcare provider before starting treatment. The medication is available under various brand names, including Firdapse. Dosage and administration should be strictly guided by a medical professional. Amifampridine is not a cure for LEMS but rather a symptomatic treatment aimed at improving quality of life for affected individuals. Its efficacy is well-documented, and it has become a standard treatment option for LEMS patients experiencing gait impairment.